For consideration of USD 20 million
Claris Lifesciences has completed the sale of its remaining 20% stake in Otsuka Pharmaceutical India, the joint venture with Otsuka Pharmaceutical Factory and Mitsui & Co. to Otsuka Pharmaceutical Factory (Japan) for a consideration of USD 20 million.Powered by Capital Market - Live News
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)